Skip to main content

Advertisement

Log in

Nonsteroidal anti-inflammatory drugs: disease modifiers in ankylosing spondylitis?

  • Practice Point
  • Published:

From Nature Clinical Practice Rheumatology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Clegg DO et al. (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39: 2004–2012

    Article  CAS  Google Scholar 

  2. Maksymowych WP et al. (2002) Ankylosing spondylitis and current disease-controlling agents: do they work? Best Pract Res Clin Rheumatol 16: 619–630

    Article  Google Scholar 

  3. Baraliakos X et al. (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52: 1216–1223

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael M Ward.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ward, M. Nonsteroidal anti-inflammatory drugs: disease modifiers in ankylosing spondylitis?. Nat Rev Rheumatol 1, 18–19 (2005). https://doi.org/10.1038/ncprheum0040

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0040

  • Springer Nature Limited

This article is cited by

Navigation